Published: Dec 28, 2021
Thailand will go ahead with its order of 2 million tablets of the Covid-19 magic pill Molnupiravir despite news that France has cancelled its order due to disappointing test results, Dr Somsak Akksilp, Department of Medical Services director-general, said on Monday.
Published: Nov 09, 2021
The Public Health Ministry on Monday explained the differences between Merck’s Molnupiravir and Pfizer’s Paxilovid pills, both of which help reduce severe symptoms and death from Covid-19. The aim is to make these drugs widely available in Thailand by early next year.
Published: Nov 05, 2021
LONDON - Regulators in Britain granted approval to the experimental drug molnupiravir from U.S. pharmaceutical giant Merck on Thursday, marking the first authorization from a public health body for an oral antiviral treatment for covid-19 in adults.
Published: Oct 28, 2021
U.S. pharmaceutical giant Merck has agreed to share its license for its experimental covid-19 drug, molnupiravir, with a nonprofit organization so that it can be manufactured widely around the world in a deal that would expand access to the treatment in more than 100 countries.
Published: Oct 21, 2021
The Bill & Melinda Gates Foundation said millions of courses of Merck & Co.s promising pill for Covid-19 could begin to reach lower-income nations early next year as the charity kicks in as much as $120 million to widen global access to the therapy.
Published: Mar 03, 2021
WASHINGTON - President Joe Biden announced Tuesday that pharmaceutical giant Merck will help make Johnson & Johnson's single-shot coronavirus vaccine - an unusual pact between fierce rivals that is among several steps intended to boost supply as Biden pushes toward having enough shots for every adult by the end of May.